Diagnosis and management of renal dysfunction in patients with cirrhosis

References

• Durand F, Valla D. Assessment of the prognosis of cirrhosis: child-Pugh versus MELD. J Hepatol. 2005;42(Suppl(1)):S100–S107.
   PubMedGoogle Scholar
• Huo TI, Lee SD, Lin HC. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int. 2008;28(5):606–613.
   PubMed Web of Science ®Google Scholar
• Gonwa TA, Mcbride MA, Anderson K, et al. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transplant. 2006;6(11):2651–2659.
   PubMed Web of Science ®Google Scholar
• Thuluvath PJ, Guidinger MK, Fung JJ, et al. Liver transplantation in the United States, 1999–2008. Am J Transplant. 2010;10(4 Pt 2):1003–1019.
   PubMed Web of Science ®Google Scholar
• Cardenas A, Gines P, Uriz J, et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology. 2001;34(4 Pt 1):671–676.
   PubMed Web of Science ®Google Scholar
• Choi YJ, Kim JH, Koo JK, et al. Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal. Clin Mol Hepatol. 2014;20(2):185–191.
   PubMedGoogle Scholar
• Warner NS, Cuthbert JA, Bhore R, et al. Acute kidney injury and chronic kidney disease in hospitalized patients with cirrhosis. J Invest Med. 2011;59(8):1244–1251.
   PubMed Web of Science ®Google Scholar
• Carvalho GC, Regis Cde A, Kalil JR, et al. Causes of renal failure in patients with decompensated cirrhosis and its impact in hospital mortality. Ann Hepatol. 2012;11(1):90–95.
   PubMed Web of Science ®Google Scholar
• Montoliu S, Balleste B, Planas R, et al. Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites. Clin Gastroenterol Hepatol. 2010;8(7):616–622. quiz e680.
   PubMed Web of Science ®Google Scholar
• Sherman DS, Fish DN, Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis. 2003;41(2):269–278.
   PubMed Web of Science ®Google Scholar
• Macaulay J, Thompson K, Kiberd BA, et al. Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better? Can J Gastroenterol. 2006;20(8):521–526.
   PubMedGoogle Scholar
• Fagundes C, Pepin MN, Guevara M, et al. Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. J Hepatol. 2012;57(2):267–273.
   PubMed Web of Science ®Google Scholar
• Verna EC, Brown RS, Farrand E, et al. Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig Dis Sci. 2012;57(9):2362–2370.
   PubMed Web of Science ®Google Scholar
• Belcher JM, Sanyal AJ, Peixoto AJ, et al. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology. 2014;60(2):622–632.
   PubMed Web of Science ®Google Scholar
• Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013;61(5):649–672.
   PubMed Web of Science ®Google Scholar
• Fagundes C, Barreto R, Guevara M, et al. A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis. J Hepatol. 2013;59(3):474–481.
   PubMed Web of Science ®Google Scholar
• Huelin P, Piano S, Sola E, et al. Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acute-on-chronic liver failure. Clin Gastroenterol Hepatol. 2017;15(3):438–445 e435.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. Electronic Address EEE, European Association for the Study of The L. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–460.
   PubMed Web of Science ®Google Scholar
• Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089–2100.
   PubMed Web of Science ®Google Scholar
• Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. J Hepatol. 2015;62(4):968–974.
   PubMed Web of Science ®Google Scholar
• Angeli P, Garcia-Tsao G, Nadim MK, et al. News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document. J Hepatol. 2019;71(4):811–822.
   PubMed Web of Science ®Google Scholar
• Shah AS, Amarapurkar DN. Spectrum of hepatitis B and renal involvement. Liver Int. 2018;38(1):23–32.
   PubMed Web of Science ®Google Scholar
• Kupin WL. Viral-associated GN: hepatitis C and HIV. Clin J Am Soc Nephrol. 2017;12(8):1337–1342.
   PubMed Web of Science ®Google Scholar
• Martin PY, Gines P, Schrier RW. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med. 1998;339(8):533–541.
   PubMed Web of Science ®Google Scholar
• Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology. 2005;41(3):422–433.
   PubMed Web of Science ®Google Scholar
• Schrier RW, Arroyo V, Bernardi M, et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;8(5):1151–1157.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Golabi P, De Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71:793–801.
   PubMed Web of Science ®Google Scholar
• Huh JH, Kim JY, Choi E, et al. The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study. PloS One. 2017;12(7):e0180951.
   PubMed Web of Science ®Google Scholar
• Musso G, Gambino R, Tabibian JH, et al. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med. 2014;11(7):e1001680.
   PubMed Web of Science ®Google Scholar
• Asrani SK, O’leary JG. The changing liver transplant waitlist: an emerging liver purgatory? Gastroenterology. 2015;148(3):493–496.
   PubMed Web of Science ®Google Scholar
• Fabrizi F, Martin P, Hepatitis MP. B and hepatitis C virus and chronic kidney disease. Acta Gastroenterol Belg. 2010;73(4):465–471.
   PubMed Web of Science ®Google Scholar
• Chan TM. Hepatitis B and renal disease. Current Hepatitis Rep. 2010;9(2):99–105.
   PubMedGoogle Scholar
• Li P, Wei RB, Tang L, et al. Clinical and pathological analysis of hepatitis B virus-related membranous nephropathy and idiopathic membranous nephropathy. Clin Nephrol. 2012;78(6):456–464.
   PubMed Web of Science ®Google Scholar
• Morales JM, Pascual-Capdevila J, Campistol JM, et al. Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. Transplantation. 1997;63(11):1634–1639.
   PubMed Web of Science ®Google Scholar
• Cosio FG, Roche Z, Agarwal A, et al. Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys. Am J Kidney Dis. 1996;28(5):752–758.
   PubMed Web of Science ®Google Scholar
• Perico N, Cattaneo D, Bikbov B, et al. Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol. 2009;4(1):207–220.
   PubMed Web of Science ®Google Scholar
• Tissandie E, Morelle W, Berthelot L, et al. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases. Kidney Int. 2011;80(12):1352–1363.
   PubMed Web of Science ®Google Scholar
• Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002;347(10):738–748.
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Chandar AK, Murad MH, et al. Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2017;2(2):94–102.
   PubMed Web of Science ®Google Scholar
• Cavallin M, Kamath PS, Merli M, et al. Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial. Hepatology. 2015;62(2):567–574.
   PubMed Web of Science ®Google Scholar
• Yang Y, Ma YP, Chen DP, et al. A meta-analysis of antiviral therapy for hepatitis B virus-associated membranous nephropathy. PloS One. 2016;11(9):e0160437.
   PubMed Web of Science ®Google Scholar
• Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009;361(13):1279–1290.
   PubMed Web of Science ®Google Scholar
• Alessandria C, Ozdogan O, Guevara M, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology. 2005;41(6):1282–1289.
   PubMed Web of Science ®Google Scholar
• Allegretti AS, Parada XV, Eneanya ND, et al. Prognosis of patients with cirrhosis and AKI who initiate RRT. Clin J Am Soc Nephrol. 2018;13(1):16–25.
   PubMed Web of Science ®Google Scholar
• Salerno F, Gerbes A, Gines P, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56(9):1310–1318.
   PubMed Web of Science ®Google Scholar
• Wong F, Leung W, Al Beshir M, et al. Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation. Liver Transplant. 2015;21(3):300–307.
   PubMed Web of Science ®Google Scholar
• Gonwa TA, Klintmalm GB, Levy M, et al. Impact of pretransplant renal function on survival after liver transplantation. Transplantation. 1995;59(3):361–365.
   PubMed Web of Science ®Google Scholar
• Lafayette RA, Pare G, Schmid CH, et al. Pretransplant renal dysfunction predicts poorer outcome in liver transplantation. Clin Nephrol. 1997;48(3):159–164.
   PubMed Web of Science ®Google Scholar
• Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology. 2002;35(5):1179–1185.
   PubMed Web of Science ®Google Scholar
• Horvatits T, Pischke S, Proske VM, et al. Outcome and natural course of renal dysfunction in liver transplant recipients with severely impaired kidney function prior to transplantation. United European Gastroenterol J. 2018;6(1):104–111.
   PubMed Web of Science ®Google Scholar
• Fede G, D’amico G, Arvaniti V, et al. Renal failure and cirrhosis: a systematic review of mortality and prognosis. J Hepatol. 2012;56(4):810–818.
   PubMed Web of Science ®Google Scholar
• Taner T, Heimbach JK, Rosen CB, et al. Decreased chronic cellular and antibody-mediated injury in the kidney following simultaneous liver-kidney transplantation. Kidney Int. 2016;89(4):909–917.
   PubMed Web of Science ®Google Scholar
• Gonwa TA, Mcbride MA, Mai ML, et al. Kidney transplantation after previous liver transplantation: analysis of the organ procurement transplant network database. Transplantation. 2011;92(1):31–35.
   PubMed Web of Science ®Google Scholar
• Asrani SK, Jennings LW, Kim WR, et al. MELD-GRAIL-Na: glomerular filtration rate and mortality on liver-transplant waiting list. Hepatology. 2019 Sep 16. Epub ahead of print.
   Google Scholar
• Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. Jama. 2013;309(7):678–688.
   PubMed Web of Science ®Google Scholar
• Francoz C, Durand F, Kahn JA, et al. Hepatorenal syndrome. Clin J Am Soc Nephrol. 2019;14(5):774–781.
   PubMed Web of Science ®Google Scholar